Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 4/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | CTRC | Q99895 | 1/20 | 0.34 |
| ▸ | CETP | P11597 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31354526 | 0.88 | CSNK1E (0.36) | RCE1KMT2ACSNK1EAOC3HDAC2 | |
| SCHEMBL19067418 | 0.86 | CETP (0.45) | CSNK1ECTRCCETP | |
| SCHEMBL31354527 | 0.85 | CSNK1E (0.38) | CSNK1EHDAC2CTRCCETPTSHR | |
| SCHEMBL31354504 | 0.84 | RCE1 (0.46) | RCE1HTTNPC1KMT2ACSNK1E | |
| SCHEMBL31354539 | 0.84 | CTRC (0.41) | CSNK1ECTRCCETPTSHR | |
| SCHEMBL4552959 | 0.84 | CETP (0.43) | CSNK1ECTRCCETPTSHR | |
| SCHEMBL31354455 | 0.83 | CETP (0.42) | CSNK1ECTRCCETP | |
| SCHEMBL31354624 | 0.83 | CETP (0.42) | CSNK1ECTRCCETP | |
| SCHEMBL31354560 | 0.83 | CETP (0.42) | CSNK1ECTRCCETP | |
| SCHEMBL31354576 | 0.83 | CETP (0.42) | CSNK1ECTRCCETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4530281-A1 | 8-(ACYLOXY)ALKANAL COMPOUND, PROCESS FOR PREPARING THE SAME AND PROCESS FOR PREPARING 2,9-DIACETOXYUNDECANE FROM THE 8-(ACYLOXY)ALKANAL COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-04-02 | — | — | EP | disclosed |
| US-20250084028-A1 | 8-(ACYLOXY)ALKANAL COMPOUND, PROCESS FOR PREPARING THE SAME AND PROCESS FOR PREPARING 2,9-DIACETOXYUNDECANE FROM THE 8-(ACYLOXY)ALKANAL COMPOUND | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-03-13 | — | — | US | disclosed |
| CN-119569571-A | 8- (Acyloxy) alkanal compound, process for producing the same, and process for producing 2, 9-diacetoxy undecane from the 8- (acyloxy) alkanal compound | 信越化学工业株式会社 | 2025-03-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250084028-A1 | 8-(ACYLOXY)ALKANAL COMPOUND, PROCESS FOR PREPARING THE SAME AND PROCESS FOR PREPARING 2,9-DIACETOXYUNDECANE FROM THE 8-(ACYLOXY)ALKANAL COMPOUND | CUL1, UBA1, UBE2E1 | RCE1 160/4885HTT 4123/4885NPC1 1447/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.